A detailed history of Brookstone Capital Management transactions in Amarin Corp Plcuk stock. As of the latest transaction made, Brookstone Capital Management holds 23,865 shares of AMRN stock, worth $12,648. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23,865
Previous 21,865 9.15%
Holding current value
$12,648
Previous $15,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$0.57 - $0.8 $1,140 - $1,600
2,000 Added 9.15%
23,865 $15,000
Q3 2023

Oct 20, 2023

BUY
$0.85 - $1.43 $9,350 - $15,730
11,000 Added 101.24%
21,865 $20,000
Q1 2023

Apr 18, 2023

SELL
$1.19 - $2.19 $982 - $1,808
-826 Reduced 7.07%
10,865 $16,000
Q4 2021

Jan 11, 2022

BUY
$3.24 - $5.18 $3,240 - $5,180
1,000 Added 9.35%
11,691 $38,000
Q3 2021

Nov 03, 2021

SELL
$3.94 - $5.84 $6,335 - $9,390
-1,608 Reduced 13.07%
10,691 $55,000
Q2 2021

Jul 14, 2021

BUY
$4.26 - $6.5 $52,393 - $79,943
12,299 New
12,299 $53,000

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $214M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Brookstone Capital Management Portfolio

Follow Brookstone Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brookstone Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Brookstone Capital Management with notifications on news.